Atria Investments’s Abiomed Inc ABMD Stock Holding History

Atria Investments’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-5,021	Closed	-$1.23M	–	814
2022 Q3	$1.23M	Buy	+5,021	New	+$1.36M	0.03%	641
2018 Q4	–	Sell	-1,017	Closed	-$457K	–	1038
2018 Q3	$457K	Buy	1,017 +20	+2%	+$7.88K	0.02%	618
2018 Q2	$408K	Buy	+997	New	+$361K	0.02%	636

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Atria Investments's ABMD Position: Q4 2022 in Review

Atria Investments sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 5,021 shares — an estimated $1.23M sold.

Atria Investments first reported a position in ABMD in Q2 2018 and held it in 3 quarters. The position peaked at $1.23M in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Atria Investments reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Atria Investments sold 5,021 Abiomed Inc shares in Q4 2022, an estimated $1.23M.
Atria Investments first reported a position in Abiomed Inc in Q2 2018 and held it in 3 quarters.
Atria Investments's Abiomed Inc position peaked at $1.23M in Q3 2022.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Atria Investments's 13F filing for Q4 2022, filed 31 Jan 2023.